World's Best Scientists 2026 revealed!
Helmut Butzkueven

Helmut Butzkueven

D-Index & Metrics

Medicine

D-Index
77
Citations
28957
World Ranking
18283
National Ranking
606

Overview

Helmut Butzkueven is affiliated with Monash University in Australia and has a substantial body of research primarily in the field of medicine, with a specialized focus on pathology and forensic medicine, neurology, oncology, immunology, and rheumatology.

The scientist's published works include prominent research articles such as:

  • Timing of high-efficacy therapy for multiple sclerosis: a retrospective observational cohort study (2020, The Lancet Neurology)
  • Epigenome-wide association studies: current knowledge, strategies and recommendations (2021, Clinical Epigenetics)
  • Long-term safety and effectiveness of natalizumab treatment in clinical practice: 10 years of real-world data from the Tysabri Observational Program (TOP) (2020, Journal of Neurology Neurosurgery & Psychiatry)
  • Comparison of switching to 6-week dosing of natalizumab versus continuing with 4-week dosing in patients with relapsing-remitting multiple sclerosis (NOVA): a randomised, controlled, open-label, phase 3b trial (2022, The Lancet Neurology)
  • Effect of Disease-Modifying Therapy on Disability in Relapsing-Remitting Multiple Sclerosis Over 15 Years (2020, Neurology)

The main topics of research covered in these studies include multiple sclerosis research studies, polyomavirus and related diseases, peripheral neuropathies and disorders, acute lymphoblastic leukemia research, rheumatoid arthritis research and therapies, systemic lupus erythematosus research, and autoimmune neurological disorders and treatments.

Frequent coauthors working alongside Butzkueven include Anneke van der Walt, Tomáš Kalinčík, Jeannette Lechner-Scott, Serkan Özakbaş, and Dana Horáková.

Notable publication venues featuring Butzkueven's research are:

  • Neurology
  • Multiple Sclerosis Journal
  • Multiple Sclerosis and Related Disorders
  • Journal of Neurology Neurosurgery & Psychiatry
  • Abstracts

The scientist's influence extends into a variety of subfields within medicine, with a significant number of publications related to pathology and forensic medicine and neurology.

Best Publications

  • Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis

    Stephen Sawcer;Garrett Hellenthal;Matti Pirinen;Chris C. A. Spencer

  • Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis

    Ashley H. Beecham;Nikolaos A. Patsopoulos;Nikolaos A. Patsopoulos;Dionysia K. Xifara;Mary F. Davis

  • Multiple Sclerosis Severity Score: Using disability and disease duration to rate disease severity

    R. H.S.R. Roxburgh;S. R. Seaman;T. Masterman;A. E. Hensiek

  • Past exposure to sun, skin phenotype, and risk of multiple sclerosis: case-control study

    I. A. F. Van Der Mei;A.-L. Ponsonby;T. Dwyer;L. Blizzard

  • Gait and balance impairment in early multiple sclerosis in the absence of clinical disability

    Clarissa L. Martin;Beverley. Phillips;Trevor. Kilpatrick;Helmut. Butzkueven

  • Association of Initial Disease-Modifying Therapy with Later Conversion to Secondary Progressive Multiple Sclerosis

    J. William L. Brown;J. William L. Brown;J. William L. Brown;Alasdair Coles;Dana Horakova;Eva Havrdova

  • Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20

    Melanie Bahlo;David R Booth;Simon A Broadley;Matthew A Brown;Matthew A Brown

  • Brain health: time matters in multiple sclerosis

    Gavin Giovannoni;Helmut Butzkueven;Suhayl Dhib-Jalbut;Jeremy Hobart

  • Defining secondary progressive multiple sclerosis.

    Johannes Lorscheider;Johannes Lorscheider;Katherine Buzzard;Katherine Buzzard;Katherine Buzzard;Vilija G Jokubaitis;Vilija G Jokubaitis;Tim Spelman

  • Vitamin D levels in people with multiple sclerosis and community controls in Tasmania, Australia

    I. A. F. van der Mei;A.-L. Ponsonby;T. Dwyer;L. Blizzard

  • Timing of high-efficacy therapy for multiple sclerosis: a retrospective observational cohort study.

    Anna He;Bernd Merkel;James William L Brown;James William L Brown;James William L Brown;Lana Zhovits Ryerson

  • Recombinant hepatitis B vaccine and the risk of multiple sclerosis: A prospective study [2] (multiple letters)

    C. R. MacIntyre;H. Kelly;D. Jolley;H. Butzkueven

  • LIF receptor signaling limits immune-mediated demyelination by enhancing oligodendrocyte survival

    Helmut Butzkueven;Jian Guo Zhang;Merja Soilu-Hanninen;Hubertus Hochrein

  • Safety and efficacy of opicinumab in acute optic neuritis (RENEW): a randomised, placebo-controlled, phase 2 trial

    Diego Cadavid;Laura Balcer;Steven Galetta;Orhan Aktas

  • Geographical Variations in Sex Ratio Trends over Time in Multiple Sclerosis

    Maria Trojano;Guglielmo Lucchese;Giusi Graziano;Bruce V. Taylor

  • Onset seizures independently predict poor outcome after subarachnoid hemorrhage

    H. Butzkueven;A. H. Evans;A. Pitman;C. Leopold

  • A randomized trial of high-dose vitamin D2 in relapsing-remitting multiple sclerosis

    M S Stein;Y Liu;Orla M Gray;J E Baker

  • MSBase : an international, online registry and platform for collaborative outcomes research in multiple sclerosis

    H Butzkueven;J Chapman;E Cristiano;F Grand'Maison

  • Defining reliable disability outcomes in multiple sclerosis

    Tomas Kalincik;Tomas Kalincik;Gary Cutter;Tim Spelman;Vilija Jokubaitis

  • Predictors of long-term disability accrual in relapse-onset multiple sclerosis.

    Vilija G. Jokubaitis;Tim Spelman;Tomas Kalincik;Johannes Lorscheider

Frequent Co-Authors

Maria Trojano
Maria Trojano University of Bari Aldo Moro
Raymond Hupperts
Raymond Hupperts Maastricht University
Eva Havrdova
Eva Havrdova Charles University
Alexandre Prat
Alexandre Prat University of Montreal
Ludwig Kappos
Ludwig Kappos University Hospital of Basel
Simon J. Foote
Simon J. Foote Australian National University
Heinz Wiendl
Heinz Wiendl University of Münster
Melanie Bahlo
Melanie Bahlo Walter and Eliza Hall Institute of Medical Research
Gary F. Egan
Gary F. Egan Monash University
Maria Pia Amato
Maria Pia Amato University of Florence

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Medicine offers diverse career opportunities beyond becoming a traditional doctor. Today, several healthcare roles require specialized knowledge and qualifications, which can often be achieved through flexible online learning options.

Many students interested in healthcare choose a health information management bachelor degree online to prepare for roles managing patient data, digital records, and healthcare information systems. Others pursue a medical coding certification, enabling them to work behind the scenes to accurately classify and code medical procedures and diagnoses.

For those aiming to provide direct patient care, affordable education options are available. Future nurse practitioners can explore the cheapest np school online programs, blending convenience and cost-effectiveness. More broadly, aspiring nurses may look into affordable online nursing programs that combine rigorous coursework with practical clinical experiences.

Whether your interest lies in administration, data, or direct care, online healthcare degrees and certifications offer flexible entry points to rewarding medical careers.

Best Scientists Citing Helmut Butzkueven

Trending Scientists